It can promote the proliferation and differentiation of human promyelocytic leukemia cells (HL-60), regulate the expression of proto-oncogenes (C-fos), control the number of cells in the gap phase, reduce DNA synthesis and transcription, induce cell differentiation, inhibit the growth of cancer cells (Deng, 2019a), and have a certain therapeutic effect on leukemia. This evidence concerns the gene FOS and leukemia.